Fatty acid metabolism-related gene expression in NAFLD (n = 26) and normal liver (n = 10) samples, which were obtained by liver biopsy, was evaluated and SREBP-1c, PPARγ, and their target gene expression in NAFLD livers were higher compared with the normal liver [24]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.